// App-Quantinova.ai

95 : HLA class II-restricted CD8+ T cells contribute to the promiscuous immune response in dapsone hypersensitive patients

Researchers

Presenter

  • Q. Zhao

Principal Investigators

  • L. Sun

  • H. Liu

  • D. Naisbitt

  • F. Zhang

Medical Centers

  • Shandong Provincial Hospital for Skin Diseases, Jinan, Shandong, China

  • University of Liverpool, Liverpool, United Kingdom

Locations

  • China

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Cluster of Differentiation 4

  • Cytotoxic T-lymphocyte-associated protein 4

  • Programmed cell death protein 1

  • Cluster of differentiation 8A

  • Major Histocompatibility Complex, Class I, B

  • Major Histocompatibility Complex, Class II, DQ Beta 1

  • T-cell receptor

Drug/Treatment

  • Dapsone

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved